Results 221 to 230 of about 52,277 (300)

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade, Nathan Morris, Diana E. Sepulveda, Alonso Cortez‐Resendiz, Christopher Brandl, Jennifer E. Lausch, Mariya Starostina, Nicholas M. Graziane   +7 more
wiley   +1 more source

The Patterns and Trajectory of Continued Opioid Use in Opioid-Naïve Patients After Curative-Intent Elective Cancer Surgery-A Prospective Cohort Study. [PDF]

Pain Pract
Lee KKH, Yiu CH, Penm J, Johns A.
europepmc   +1 more source

[Opioid analgesics].

Vojnosanitetski pregled, 2004
Sonja, Vucković, Milica, Prostran, Milovan, Ivanović, Zoran, Todorović, Radan, Stojanović, Zorica, Nesić, Ivana, Matić, Slobodan, Milovanović   +7 more
openaire   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

British Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman, Christopher J. Black, Andrea Shin, Daniel Keszthelyi   +3 more
wiley   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Tapentadol-induced urticarial rash in a patient with acute pancreatitis.

Indian J Pharmacol
Deshidi S, Hanumanthu V, Mahajan G, Appasani S.   +3 more
europepmc   +1 more source

Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST). [PDF]

Drug Alcohol Rev
Degenhardt L, Farrell M, Doyle M, Stone J, Bharat C, Hickman M, Martinello M, Weatherburn D, Dean K, Coyte J, Macdonald C, Harrod ME, Grant L, Larman G, Vickerman P, McGrath C, Thompson P, Churchill A, Dore G, Santo T.   +19 more
europepmc   +1 more source

5‐HT2A receptor agonism by tert‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose New synthetic cannabinoid receptor agonists (SCRAs) are associated with severe adverse effects, including unexpected psychiatric symptoms. These compounds are mainly active through their potent agonism on the cannabinoid receptors CB1 and CB2.
Giorgia Corli, Deborah Rudin, Dino Luethi, Matthias E. Liechti, Sabrine Bilel, Matteo Marti, Henrik Green, Manuela Carla Monti, Caitlyn Norman   +8 more
wiley   +1 more source

Assessment of Pediatric Nurses' Knowledge Regarding Pain Management in Children in Public Hospitals in Greece. [PDF]

Cureus
Albani EN, Strakantouna E, Rigatos S, Togas C, Sotiriadou C, Petsios KT, Tzenalis A.   +6 more
europepmc   +1 more source